GABPB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.869000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.452600E-01
Normal-vs-Stage2
5.450400E-01
Normal-vs-Stage3
1.541810E-01
Normal-vs-Stage4
8.788400E-01
Stage1-vs-Stage2
2.014200E-01
Stage1-vs-Stage3
1.435180E-01
Stage1-vs-Stage4
8.278300E-02
Stage2-vs-Stage3
1.607640E-01
Stage2-vs-Stage4
3.647200E-01
Stage3-vs-Stage4
6.260200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.395000E-01
Normal-vs-AfricanAmerican
4.531600E-01
Normal-vs-Asian
6.729700E-02
Caucasian-vs-AfricanAmerican
7.144400E-01
Caucasian-vs-Asian
7.560400E-02
AfricanAmerican-vs-Asian
2.868400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.322200E-01
Normal-vs-Female
4.366600E-01
Male-vs-Female
8.998800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.807200E-01
Normal-vs-Age(41-60Yrs)
8.482800E-01
Normal-vs-Age(61-80Yrs)
3.596600E-01
Normal-vs-Age(81-100Yrs)
1.831760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.279400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.914200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.423400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.012500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.644000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.766850E-01
Normal-vs-Daily Drinker
6.076200E-01
Normal-vs-Weekly Drinker
3.735200E-01
Normal-vs-Occasional Drinker
9.261200E-01
Normal-vs-Social Drinker
2.490400E-01
Non Drinker-vs-Daily Drinker
3.149000E-01
Non Drinker-vs-Weekly Drinker
6.209000E-01
Non Drinker-vs-Occasional Drinker
7.415800E-02
Non Drinker-vs-Social Drinker
5.141400E-01
Daily Drinker-vs-Weekly Drinker
6.628400E-01
Daily Drinker-vs-Occasional Drinker
2.987200E-01
Daily Drinker-vs-Social Drinker
6.350000E-01
Weekly Drinker-vs-Occasional Drinker
1.741210E-01
Weekly Drinker-vs-Social Drinker
9.453600E-01
Occasional Drinker-vs-Social Drinker
1.540790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.612800E-01
Normal-vs-Grade 2
1.136180E-01
Normal-vs-Grade 3
7.232100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.021600E-02
Grade 1-vs-Grade 3
7.812300E-02
Grade 1-vs-Grade 4
3.612800E-01
Grade 2-vs-Grade 3
9.337800E-01
Grade 2-vs-Grade 4
1.136180E-01
Grade 3-vs-Grade 4
7.232100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.776000E-01
Normal-vs-NonDiabetic
4.228600E-01
Diabetic-vs-NonDiabetic
6.233800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.339600E-01
Normal-vs-NoPancreatitis
5.334200E-01
Pancreatitis-vs-NoPancreatitis
1.207850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.566000E-01
Normal-vs-N1
6.063000E-01
N0-vs-N1
1.382410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.117200E-01
Normal-vs-TP53-NonMutant
2.171400E-01
TP53-Mutant-vs-TP53-NonMutant
7.901400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
